| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |